IMVT
#1015
Immunovant, Inc. - Common Stock
41.2 0 USD
-0.06%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.98%
Changement Mensuel
+6.71%
Evolution sur 6 mois
+50.53%
Changement Annuel
+114.47%
Clôture Précédente
43.8 2
Open
41.2 0
Low
41.2 0
High
41.2 0
Volume
155
Financials
- Market Capitalization 8.51 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.97
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 992 |  PCVX Vaxcyte, Inc. - Common Stock | 59.84 USD | -2.16% | -3.95% | +13.01% | +41.47% | 8.90 B USD | ||
| 1013 |  IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +11.50% | +244.02% | 8.53 B USD | ||
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1040 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD |